NDC 23731-7000

Rejuvesol

Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, And Sodium Phosphate, Monobasic, Monohydrate

Rejuvesol is a Extracorporeal Solution in the Human Prescription Drug category. It is labeled and distributed by Citra Labs Llc. The primary component is Sodium Pyruvate; Inosine; Adenine; Sodium Phosphate, Dibasic; Sodium Phosphate, Monobasic, Monohydrate.

• Product ID: 23731-7000_65e6764d-4cf1-ffc1-e053-2991aa0ab6db
• NDC: 23731-7000
• Product Type: Human Prescription Drug
• Proprietary Name: Rejuvesol
• Generic Name: Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, And Sodium Phosphate, Monobasic, Monohydrate
• Dosage Form: Solution
• Route of Administration: EXTRACORPOREAL
• Marketing Start Date: 1997-02-26
• Marketing Category: NDA / NDA
• Application Number: BN950522
• Labeler Name: Citra Labs LLC
• Substance Name: SODIUM PYRUVATE; INOSINE; ADENINE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
• Active Ingredient Strength: 1 g/50mL; g/50mL; g/50mL; g/50mL; g/50mL
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 23731-7000-5

12 VIAL, SINGLE-USE in 1 CASE (23731-7000-5) > 50 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 1997-02-26
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 23731-7000-5 [23731700005]

Rejuvesol SOLUTION

• Marketing Category: NDA
• Application Number: BN950522
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1997-02-26

Drug Details

Active Ingredients

Ingredient	Strength
SODIUM PYRUVATE	.55 g/50mL

OpenFDA Data

• SPL SET ID: bc06c40f-81a0-45e5-80b6-61f67d445068
• Manufacturer:
  • Citra Labs LLC
• UNII:
  • 593YOG76RN
  • POD38AIF08
  • GR686LBA74
  • 5A614L51CT
  • JAC85A2161